U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Food
  3. News & Events from HFP
  4. Workshops, Meetings & Webinars on Food and Dietary Supplements
  5. Infant Formula Transition Plan for Exercise of Enforcement Discretion Stakeholder Call - 10/05/2022
  1. Workshops, Meetings & Webinars on Food and Dietary Supplements

Webcast | Virtual

Event Title
Infant Formula Transition Plan for Exercise of Enforcement Discretion Stakeholder Call
October 5, 2022

Date:
October 5, 2022
Time:
2:00 p.m. ET

The U.S. Food & Drug Administration (FDA) will host a call for stakeholders on Wednesday, October 5, 2022 at 2 p.m. ET to provide a high-level overview of the Infant Formula Transition Plan for Exercise of Enforcement Discretion and address questions.

The guidance outlines a pathway for manufacturers of infant formula under enforcement discretion to market infant formula products that may not currently comply with specific FDA requirements while they work toward meeting those requirements. Under the new guidance, the period of enforcement discretion for those products identified in the letters of enforcement discretion will be extended until Jan. 6, 2023, with further extensions possible for firms that express interest in and take steps toward the lawful marketing of such products in the United States. The guidance balances the need to ensure that infant formula products meet regulatory requirements with the need for a more resilient infant formula supply.

Call Link: Infant Formula Transition Plan for Exercise of Enforcement Discretion Stakeholder Call - YouTube

Agenda

  • Welcome and Introduction of Speakers/Technical Experts 
    LCDR Janesia Robbs, Communications and Public Engagement Staff, Center for Food Safety and Applied Nutrition (CFSAN), FDA
  • Opening Remarks
    Dr. Claudine Kavanaugh, Director, Office of Nutrition and Food Labeling, CFSAN, FDA
  • Overview of Infant Formula Transition Plan for Exercise of Enforcement Discretion
    Dr. Patricia A. Hansen, Deputy Director, Office of Nutrition and Food Labeling, CFSAN, FDA
  • Question & Answer Session
    LCDR Janesia Robbs, Communications and Public Engagement Staff, CFSAN, FDA
    • Dr. Claudine Kavanaugh, Director, Office of Nutrition and Food Labeling, CFSAN, FDA
    • Dr. Patricia A. Hansen, Deputy Director, Office of Nutrition and Food Labeling, CFSAN, FDA

Additional Information 

Back to Top